Drug Shortage Report for METHOTREXATE INJECTION USP
Report ID | 44783 |
Drug Identification Number | 02398427 |
Brand name | METHOTREXATE INJECTION USP |
Common or Proper name | METHOTREXATE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2ML VIAL |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-03-23 |
Estimated end date | 2018-06-15 |
Actual end date | 2018-06-26 |
Shortage status | Resolved |
Updated date | 2018-07-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-07-03 | French | Compare |
v7 | 2018-07-03 | English | Compare |
v6 | 2018-05-07 | French | Compare |
v5 | 2018-05-07 | English | Compare |
v4 | 2018-04-20 | French | Compare |
v3 | 2018-04-20 | English | Compare |
v2 | 2018-04-03 | French | Compare |
v1 | 2018-04-03 | English | Compare |
Showing 1 to 8 of 8